These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7963731)

  • 61. Human immune response to HIV-1-Nef. I. CD45RO- T lymphocytes of non-infected donors contain cytotoxic T lymphocyte precursors at high frequency.
    Lucchiari M; Niedermann G; Leipner C; Meyerhans A; Eichmann K; Maier B
    Int Immunol; 1994 Nov; 6(11):1739-49. PubMed ID: 7865467
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Evidence of presentation of multiple HIV-1 cytotoxic T lymphocyte epitopes by HLA-B*3501 molecules that are associated with the accelerated progression of AIDS.
    Tomiyama H; Miwa K; Shiga H; Moore YI; Oka S; Iwamoto A; Kaneko Y; Takiguchi M
    J Immunol; 1997 May; 158(10):5026-34. PubMed ID: 9144523
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Elicitation of high-frequency cytotoxic T-lymphocyte responses against both dominant and subdominant simian-human immunodeficiency virus epitopes by DNA vaccination of rhesus monkeys.
    Barouch DH; Craiu A; Santra S; Egan MA; Schmitz JE; Kuroda MJ; Fu TM; Nam JH; Wyatt LS; Lifton MA; Krivulka GR; Nickerson CE; Lord CI; Moss B; Lewis MG; Hirsch VM; Shiver JW; Letvin NL
    J Virol; 2001 Mar; 75(5):2462-7. PubMed ID: 11160750
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lymphocyte proliferative responses to HIV-1 envelope and core antigens by infected and uninfected adults and children.
    Borkowsky W; Krasinski K; Moore T; Papaevangelou V
    AIDS Res Hum Retroviruses; 1990 May; 6(5):673-8. PubMed ID: 2113821
    [TBL] [Abstract][Full Text] [Related]  

  • 65. HIV-specific cytotoxic T lymphocytes in seropositive individuals.
    Walker BD; Chakrabarti S; Moss B; Paradis TJ; Flynn T; Durno AG; Blumberg RS; Kaplan JC; Hirsch MS; Schooley RT
    Nature; 1987 Jul 23-29; 328(6128):345-8. PubMed ID: 3496541
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Protection of rhesus monkeys against infection with minimally pathogenic simian-human immunodeficiency virus: correlations with neutralizing antibodies and cytotoxic T cells.
    Quinnan GV; Yu XF; Lewis MG; Zhang PF; Sutter G; Silvera P; Dong M; Choudhary A; Sarkis PT; Bouma P; Zhang Z; Montefiori DC; Vancott TC; Broder CC
    J Virol; 2005 Mar; 79(6):3358-69. PubMed ID: 15731230
    [TBL] [Abstract][Full Text] [Related]  

  • 67. HIV-specific cytotoxic T lymphocytes directed against alveolar macrophages in HIV-infected patients.
    Autran B; Plata F; Guillon JM; Joly P; Mayaud C; Debré P
    Res Virol; 1990; 141(2):131-6. PubMed ID: 2189171
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Multiple cytotoxic effector cells are induced by infection with the human immunodeficiency virus.
    Rivière Y; Tanneau-Salvadori F; Regnault A; Lopez O; Sansonetti P; Guy B; Kieny MP; Fournel JJ; Montagnier L
    Res Immunol; 1989 Jan; 140(1):110-5; discussion 121. PubMed ID: 2657908
    [No Abstract]   [Full Text] [Related]  

  • 69. Why high levels of virus-specific CTL persist in HIV1-infected individuals.
    Koup RA; Sullivan JL
    Res Immunol; 1989 Jan; 140(1):92-5; discussion 118-9. PubMed ID: 2543042
    [No Abstract]   [Full Text] [Related]  

  • 70. How do CD8+ T lymphocytes control HIV replication in vivo?
    Walker CM
    Res Immunol; 1989 Jan; 140(1):115-8; discussion 122-3. PubMed ID: 2499020
    [No Abstract]   [Full Text] [Related]  

  • 71. Immune surveillance and AIDS progression.
    Zinkernagel R; Klenerman P
    Curr Biol; 1997 Jul; 7(7):R403-5. PubMed ID: 9210384
    [No Abstract]   [Full Text] [Related]  

  • 72. High expression of APO-1 (CD95) on T lymphocytes from human immunodeficiency virus-1-infected children.
    Debatin KM; Fahrig-Faissner A; Enenkel-Stoodt S; Kreuz W; Benner A; Krammer PH
    Blood; 1994 May; 83(10):3101-3. PubMed ID: 7514053
    [No Abstract]   [Full Text] [Related]  

  • 73. Naive and memory T-cells in HIV-infected children.
    Duse M; Airò P; Prati E; Soresina A; Notarangelo LD; Cattaneo R; Ugazio AG
    Eur J Pediatr; 1994 Apr; 153(4):301. PubMed ID: 7910797
    [No Abstract]   [Full Text] [Related]  

  • 74. Lack of transmission of the human immunodeficiency virus by unusual "needlestick" injuries.
    Ziegler JB; Robertson PW; Campbell P
    Med J Aust; 1988 Aug; 149(3):161-2. PubMed ID: 3165157
    [No Abstract]   [Full Text] [Related]  

  • 75. HIV-specific cytotoxic T lymphocytes.
    Plata F
    Res Immunol; 1989 Jan; 140(1):89-91. PubMed ID: 2657912
    [No Abstract]   [Full Text] [Related]  

  • 76. Virus interactions with dendritic cells.
    Klagge IM; Schneider-Schaulies S
    J Gen Virol; 1999 Apr; 80 ( Pt 4)():823-833. PubMed ID: 10211949
    [No Abstract]   [Full Text] [Related]  

  • 77. Immunization of HIV-infected children.
    Onorato IM; Orenstein WA
    J Pediatr; 1988 Feb; 112(2):333-4. PubMed ID: 3339522
    [No Abstract]   [Full Text] [Related]  

  • 78. Impact of maternal HIV exposure, feeding status, and microbiome on infant cellular immunity.
    Dzanibe S; Jaspan HB; Zulu MZ; Kiravu A; Gray CM
    J Leukoc Biol; 2019 Feb; 105(2):281-289. PubMed ID: 30577072
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Direct Detection of T- and B-Memory Lymphocytes by ImmunoSpot® Assays Reveals HCMV Exposure that Serum Antibodies Fail to Identify.
    Terlutter F; Caspell R; Nowacki TM; Lehmann A; Li R; Zhang T; Przybyla A; Kuerten S; Lehmann PV
    Cells; 2018 May; 7(5):. PubMed ID: 29783767
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The Immune System of HIV-Exposed Uninfected Infants.
    Abu-Raya B; Kollmann TR; Marchant A; MacGillivray DM
    Front Immunol; 2016; 7():383. PubMed ID: 27733852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.